EsopH is a liquid gel, packed in convenient single-dose sachet. Our patented formula – a fixed combination of Chondroitin Sulfate and Hyaluronic Acid has demonstrated to be effective in treating acid reflux, with a rapid onset of action.
Our Key Ingredients
Hyaluronic Acid is an active hydrophilic substance shaping a viscous liquid formulation. HA coats the esophageal mucosa limiting the contact of refluxed acid and pepsin with the epithelial surface.
Topical HA formulations are used to treat recurrent aphthous ulcerations of the oral mucosa with fast symptom relief, to which the anti-inflammatory activity of the compound may also contribute.
Chondroitin Sulphate is a natural glycosaminoglycan that is present in the extracellular matrix surrounding cells, especially in the cartilage, skin, ligaments and tendons. CS fulfills important biological functions such as:
CS may display specific binding to bioactive molecules therefore reducing peptic activity and neutralizing the negative effect on the esophageal mucosa.
Poloxamer 407 formulation is a bioadhesive carrier that prolongs the contact time of chondroitin sulphate and hyaluronic acid with the esophegeal mucosa.
Poloxamer 407 is also a hydrophilic non-ionic surfactant that enhances the solubilization of poorly water-soluble drugs.
EsopH® liquid gel can be taken orally as needed (Up to 4 times a day)
EsopH® can be used as a compliment or substitute to PPI’s (Proton Pump Inhibitor’s)